\-\ Texto\\:\\ \ \(0\)\
\-\ pleasant\\,\\ high\\ functioning\\ elderly\\ female\\ without\\ abnormal\\ physical\\ exam\\ abnormalities\\.\ \(0\)\
\-\ pet\\/ct\\ showed\\ no\\ evidence\\ of\\ metastasis\\.\\ multiple\\ treatment\\ options\\ to\\ include\\ left\\ lower\\ lobectomy\\/wedge\\ resection\\ were\\ considered\\.\\ \\ however\\,\\ given\\ advanced\\ age\\ and\\ low\\ grade\\ adenocarcinoma\\,\\ the\\ patient\\ opted\\ for\\ definitive\\ external\\ beam\\ irradiation\\.\ \(0\)\
\-\ 1\\.2\\ x\\ 1\\.4\\ cm\\ left\\ lower\\ lobe\\ ground\\ glass\\ pulmonary\\ nodule\\ without\\ significant\\ metabolic\\ activity\\.\\ of\\ note\\,\\ chest\\ ct\\ one\\ year\\ prior\\ showed\\ correlating\\ 1\\.0\\ cm\\ pulmonary\\ nodule\\.\ \(0\)\
\-\ adenocarcinoma\\ of\\ the\\ lung\\.\ \(2\)\
\-\ infection\\/inflammation\\:\\ atypical\\ or\\ early\\ bacterial\\.\ \(0\)\
\-\ tumor\\:\\ low\\ grade\\ \\(e\\.g\\.\\,\\ bronchioloalveolar\\)\\ or\\ well\\ differentiated\\ adenocarcinoma\\;\\ mucinous\\ tumors\\ \\(e\\.g\\.\\,\\ bronchioloalveolar\\)\\;\\ carcinoid\\;\\ mucoepidermoid\\ carcinoma\\;\\ adenoid\\ cystic\\ carcinoma\\;\\ pleomorphic\\ carcinoma\\.\\ most\\ metastasis\\ and\\ lymphoma\\ are\\ unlikely\\ given\\ the\\ lack\\ of\\ significant\\ activity\\.\ \(0\)\
\-\ 86\\ year\\ old\\ female\\ with\\ history\\ of\\ esophageal\\ cancer\\ status\\ post\\ esophagectomy\\ presents\\ with\\ unexplained\\ weight\\ loss\\ \\(30\\ pounds\\ over\\ past\\ 2\\ years\\)\\.\\ \\ 18\\-fdg\\ pet\\/ct\\ performed\\.\ \(0\)\
\-\ though\\ extremely\\ valuable\\ in\\ the\\ workup\\ and\\ evaluation\\ of\\ cancer\\ patients\\,\\ among\\ several\\ factors\\ such\\ as\\ lesion\\ size\\,\\ f\\-18\\ fdg\\ pet\\ imaging\\ is\\ dependent\\ on\\ the\\ enhanced\\ glycolytic\\ rate\\ \\(aka\\ metabolic\\ activity\\)\\ of\\ malignant\\ cells\\ to\\ demonstrate\\ elevated\\ suvs\\.\\ \\ thus\\,\\ many\\ low\\ grade\\ or\\ well\\-differentiated\\ tumors\\ will\\ not\\ demonstrate\\ increased\\ fdg\\ avidity\\.\\ \\ classic\\ examples\\ include\\ bronchoalveolar\\ carcinoma\\ \\(low\\ grade\\ adenocarcinoma\\)\\ and\\ carcinoid\\.\\ \\ \ \(0\)\
\-\ at\\ times\\,\\ borderline\\ elevated\\ \\(above\\ 2\\.5\\)\\ suvs\\ can\\ be\\ seen\\ in\\ these\\ tumors\\ which\\ further\\ complicates\\ specificity\\.\\ \\ one\\ strategum\\ for\\ differentiating\\ infectious\\/inflammatory\\ pulmonary\\ lesions\\ from\\ tumor\\ is\\ dual\\-time\\ point\\ imaging\\,\\ where\\ a\\ second\\ more\\ delayed\\ pet\\ is\\ performed\\ and\\ compared\\ with\\ initial\\ imaging\\.\\ \\ classically\\,\\ infection\\/inflammation\\ suv\\ decreases\\,\\ and\\ tumor\\ suv\\ increases\\.\\ \\ alternatively\\,\\ other\\ pet\\ radiopharmaceuticals\\ can\\ be\\ used\\,\\ such\\ as\\ c11\\ acetate\\,\\ although\\ these\\ isotopes\\ are\\ still\\ largely\\ experimental\\,\\ not\\ routinely\\ available\\,\\ and\\ only\\ fdg\\ is\\ currently\\ cms\\ approved\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ fdg\\:\\ 0\\.04961983826736621\ \(0\)\
\-\ infection\\/inflammation\\:\\ 0\\.04593396509106183\ \(0\)\
\-\ suvs\\:\\ 0\\.04422157180265838\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.04394707672099094\ \(0\)\
\-\ bronchioloalveolar\\:\\ 0\\.042893336378169035\ \(0\)\
\-\ pet\\:\\ 0\\.04004272396143006\ \(0\)\
\-\ grade\\:\\ 0\\.03874805705894012\ \(0\)\
\-\ pet\\/ct\\:\\ 0\\.03635397751704933\ \(0\)\
\-\ e\\.g\\.\\:\\ 0\\.03635397751704933\ \(0\)\
\-\ suv\\:\\ 0\\.0349469014571432\ \(0\)\
\-\ carcinoid\\:\\ 0\\.030225290510018626\ \(0\)\
\-\ \\;\\:\\ 0\\.030140196256735023\ \(0\)\
\-\ carcinoma\\:\\ 0\\.028832472262093647\ \(0\)\
\-\ tumors\\:\\ 0\\.028658181764915185\ \(0\)\
\-\ activity\\:\\ 0\\.028625416328406594\ \(0\)\
\-\ low\\:\\ 0\\.028287714915076183\ \(0\)\
\-\ lobectomy\\/wedge\\:\\ 0\\.02623666197609077\ \(0\)\
\-\ glycolytic\\:\\ 0\\.02623666197609077\ \(0\)\
\-\ strategum\\:\\ 0\\.02623666197609077\ \(0\)\
\-\ dual\\-time\\:\\ 0\\.02623666197609077\ \(0\)\
\-\ c11\\:\\ 0\\.02623666197609077\ \(0\)\
\-\ isotopes\\:\\ 0\\.02623666197609077\ \(0\)\
\-\ cms\\:\\ 0\\.02623666197609077\ \(0\)\
\-\ metabolic\\:\\ 0\\.02512142008233279\ \(0\)\
\-\ 18\\-fdg\\:\\ 0\\.02417372393870998\ \(0\)\
\-\ avidity\\:\\ 0\\.02417372393870998\ \(0\)\
\-\ radiopharmaceuticals\\:\\ 0\\.02417372393870998\ \(0\)\
\-\ pulmonary\\:\\ 0\\.022290627769821995\ \(0\)\
\-\ complicates\\:\\ 0\\.02211078590132919\ \(0\)\
\-\ infectious\\/inflammatory\\:\\ 0\\.02211078590132919\ \(0\)\
\-\ acetate\\:\\ 0\\.02211078590132919\ \(0\)\
\-\ nodule\\:\\ 0\\.020965557138345272\ \(0\)\
\-\ mucoepidermoid\\:\\ 0\\.020904044508150126\ \(0\)\
\-\ approved\\:\\ 0\\.020904044508150126\ \(0\)\
\-\ f\\-18\\:\\ 0\\.020445262722949952\ \(0\)\
\-\ experimental\\:\\ 0\\.020445262722949952\ \(0\)\
\-\ esophagectomy\\:\\ 0\\.0200478478639484\ \(0\)\
\-\ unexplained\\:\\ 0\\.0200478478639484\ \(0\)\
\-\ opted\\:\\ 0\\.019697303114971067\ \(0\)\
\-\ well\\-differentiated\\:\\ 0\\.019383730151703728\ \(0\)\
\-\ pleasant\\:\\ 0\\.019100068902286094\ \(0\)\
\-\ valuable\\:\\ 0\\.019100068902286094\ \(0\)\
\-\ routinely\\:\\ 0\\.019100068902286094\ \(0\)\
\-\ metastasis\\:\\ 0\\.01904016265654718\ \(0\)\
\-\ irradiation\\:\\ 0\\.01860288412650286\ \(0\)\
\-\ correlating\\:\\ 0\\.01860288412650286\ \(0\)\
\-\ examples\\:\\ 0\\.018382324685569162\ \(0\)\
\-\ alternatively\\:\\ 0\\.018382324685569162\ \(0\)\
\-\ bronchoalveolar\\:\\ 0\\.018176988758524665\ \(0\)\
\-\ adenoid\\:\\ 0\\.01798490982656761\ \(0\)\
\-\ aka\\:\\ 0\\.01798490982656761\ \(0\)\
\-\ imaging\\:\\ 0\\.017875659146925023\ \(0\)\
\-\ tumor\\:\\ 0\\.017787788407239383\ \(0\)\
\-\ given\\:\\ 0\\.017436990431644896\ \(0\)\
\-\ differentiating\\:\\ 0\\.017320792114322938\ \(0\)\
\-\ decreases\\:\\ 0\\.017320792114322938\ \(0\)\
\-\ elevated\\:\\ 0\\.017257835484280136\ \(0\)\
\-\ beam\\:\\ 0\\.017175583292390103\ \(0\)\
\-\ 86\\:\\ 0\\.017175583292390103\ \(0\)\
\-\ borderline\\:\\ 0\\.016778168433388547\ \(0\)\
\-\ cancer\\:\\ 0\\.016721221811695032\ \(0\)\
\-\ showed\\:\\ 0\\.016677400404307718\ \(0\)\
\-\ functioning\\:\\ 0\\.01653994608912207\ \(0\)\
\-\ specificity\\:\\ 0\\.01653994608912207\ \(0\)\
\-\ largely\\:\\ 0\\.01653994608912207\ \(0\)\
\-\ 1\\.4\\:\\ 0\\.01621494819636912\ \(0\)\
\-\ 1\\.2\\:\\ 0\\.016016461962742118\ \(0\)\
\-\ such\\:\\ 0\\.01590079041571936\ \(0\)\
\-\ 1\\.0\\:\\ 0\\.01583038947172624\ \(0\)\
\-\ pounds\\:\\ 0\\.01583038947172624\ \(0\)\
\-\ mucinous\\:\\ 0\\.015257854076942147\ \(0\)\
\-\ among\\:\\ 0\\.015112645255009313\ \(0\)\
\-\ elderly\\:\\ 0\\.014974192827524513\ \(0\)\
\-\ increases\\:\\ 0\\.014907309327964817\ \(0\)\
\-\ classically\\:\\ 0\\.014841895915111319\ \(0\)\
\-\ glass\\:\\ 0\\.01471523039600776\ \(0\)\
\-\ \\,\\:\\ 0\\.014502324938426108\ \(0\)\
\-\ extremely\\:\\ 0\\.01447700805174128\ \(0\)\
\-\ pleomorphic\\:\\ 0\\.014310075115279841\ \(0\)\
\-\ include\\:\\ 0\\.01426877076208504\ \(0\)\
\-\ performed\\:\\ 0\\.014182013876353088\ \(0\)\
\-\ ground\\:\\ 0\\.014001918332717817\ \(0\)\
\-\ one\\:\\ 0\\.01378411537684907\ \(0\)\
\-\ 2\\.5\\:\\ 0\\.013767451434345452\ \(0\)\
\-\ dependent\\:\\ 0\\.013722695846950989\ \(0\)\
\-\ significant\\:\\ 0\\.013677661613417996\ \(0\)\
\-\ cm\\:\\ 0\\.01364259593938682\ \(0\)\
\-\ differentiated\\:\\ 0\\.013592330898562913\ \(0\)\
\-\ these\\:\\ 0\\.013237170785463333\ \(0\)\
\-\ workup\\:\\ 0\\.013085350643362798\ \(0\)\
\-\ advanced\\:\\ 0\\.013014485617488636\ \(0\)\
\-\ bacterial\\:\\ 0\\.013014485617488636\ \(0\)\
\-\ \\(\\:\\ 0\\.012899316540068937\ \(0\)\
\-\ \\)\\:\\ 0\\.012741744502023304\ \(0\)\
\-\ thus\\:\\ 0\\.012652292358626971\ \(0\)\
\-\ definitive\\:\\ 0\\.012560710041166394\ \(0\)\
\-\ options\\:\\ 0\\.012357378957900093\ \(0\)\
\-\ times\\:\\ 0\\.012329433302096997\ \(0\)\
\-\ unlikely\\:\\ 0\\.012114840165485858\ \(0\)\
\-\ still\\:\\ 0\\.012114840165485858\ \(0\)\
\-\ without\\:\\ 0\\.01197626884737\ \(0\)\
\-\ though\\:\\ 0\\.01179609571442524\ \(0\)\
\-\ demonstrate\\:\\ 0\\.011705072269839528\ \(0\)\
\-\ esophageal\\:\\ 0\\.011659757809570199\ \(0\)\
\-\ lack\\:\\ 0\\.011572216484551468\ \(0\)\
\-\ can\\:\\ 0\\.01153703781231589\ \(0\)\
\-\ lower\\:\\ 0\\.011439655174784897\ \(0\)\
\-\ factors\\:\\ 0\\.011424954409362868\ \(0\)\
\-\ point\\:\\ 0\\.011113434699351294\ \(0\)\
\-\ atypical\\:\\ 0\\.011022412605982008\ \(0\)\
\-\ enhanced\\:\\ 0\\.01088233072842848\ \(0\)\
\-\ external\\:\\ 0\\.010814687124030992\ \(0\)\
\-\ compared\\:\\ 0\\.010764944621132954\ \(0\)\
\-\ female\\:\\ 0\\.010456906377665677\ \(0\)\
\-\ many\\:\\ 0\\.010453016416391138\ \(0\)\
\-\ where\\:\\ 0\\.010379887664217014\ \(0\)\
\-\ delayed\\:\\ 0\\.010351131976979702\ \(0\)\
\-\ considered\\:\\ 0\\.01026649526471621\ \(0\)\
\-\ cells\\:\\ 0\\.010197758018303563\ \(0\)\
\-\ currently\\:\\ 0\\.01007789522325017\ \(0\)\
\-\ rate\\:\\ 0\\.009912861578797151\ \(0\)\
\-\ note\\:\\ 0\\.009815671212802947\ \(0\)\
\-\ 30\\:\\ 0\\.009780027787068674\ \(0\)\
\-\ second\\:\\ 0\\.009768240878687435\ \(0\)\
\-\ used\\:\\ 0\\.009756500467107028\ \(0\)\
\-\ classic\\:\\ 0\\.009744806186928785\ \(0\)\
\-\ abnormalities\\:\\ 0\\.009341561374101835\ \(0\)\
\-\ above\\:\\ 0\\.0093212460018685\ \(0\)\
\-\ early\\:\\ 0\\.009301068362031064\ \(0\)\
\-\ malignant\\:\\ 0\\.009192472251128871\ \(0\)\
\-\ weight\\:\\ 0\\.009115910074824003\ \(0\)\
\-\ status\\:\\ 0\\.009078355122564444\ \(0\)\
\-\ or\\:\\ 0\\.008942167401461674\ \(0\)\
\-\ although\\:\\ 0\\.00858907523981132\ \(0\)\
\-\ available\\:\\ 0\\.008549759073927967\ \(0\)\
\-\ size\\:\\ 0\\.008526416283865391\ \(0\)\
\-\ initial\\:\\ 0\\.008427327807378893\ \(0\)\
\-\ x\\:\\ 0\\.008390078379010348\ \(0\)\
\-\ several\\:\\ 0\\.008175871534888059\ \(0\)\
\-\ further\\:\\ 0\\.00808763137440553\ \(0\)\
\-\ past\\:\\ 0\\.008080950809364386\ \(0\)\
\-\ post\\:\\ 0\\.008008437598429445\ \(0\)\
\-\ will\\:\\ 0\\.007956788745176017\ \(0\)\
\-\ resection\\:\\ 0\\.007931296593810174\ \(0\)\
\-\ be\\:\\ 0\\.00784379001990434\ \(0\)\
\-\ age\\:\\ 0\\.007740804540310436\ \(0\)\
\-\ as\\:\\ 0\\.007693913725560284\ \(0\)\
\-\ only\\:\\ 0\\.007647058507395641\ \(0\)\
\-\ years\\:\\ 0\\.007467985526840721\ \(0\)\
\-\ evaluation\\:\\ 0\\.007387615463770261\ \(0\)\
\-\ loss\\:\\ 0\\.00738233384663226\ \(0\)\
\-\ lung\\:\\ 0\\.0073665450007105535\ \(0\)\
\-\ not\\:\\ 0\\.007350111141321044\ \(0\)\
\-\ cystic\\:\\ 0\\.007335216390630233\ \(0\)\
\-\ lymphoma\\:\\ 0\\.007268448316635374\ \(0\)\
\-\ abnormal\\:\\ 0\\.00725325071522295\ \(0\)\
\-\ however\\:\\ 0\\.007081452546419852\ \(0\)\
\-\ high\\:\\ 0\\.00695995851510957\ \(0\)\
\-\ are\\:\\ 0\\.006933773050771438\ \(0\)\
\-\ lobe\\:\\ 0\\.006843230202153374\ \(0\)\
\-\ lesions\\:\\ 0\\.00680821579269032\ \(0\)\
\-\ \\:\\:\\ 0\\.00672782628565872\ \(0\)\
\-\ is\\:\\ 0\\.0066939378379134\ \(0\)\
\-\ evidence\\:\\ 0\\.006667983879068088\ \(0\)\
\-\ patients\\:\\ 0\\.006582067260017934\ \(0\)\
\-\ prior\\:\\ 0\\.0065300975363165575\ \(0\)\
\-\ over\\:\\ 0\\.006475126756368936\ \(0\)\
\-\ more\\:\\ 0\\.006360643777714781\ \(0\)\
\-\ physical\\:\\ 0\\.0062395990166108275\ \(0\)\
\-\ increased\\:\\ 0\\.006221680898213261\ \(0\)\
\-\ chest\\:\\ 0\\.006085502976361662\ \(0\)\
\-\ most\\:\\ 0\\.005871533159904988\ \(0\)\
\-\ other\\:\\ 0\\.0058620194901858585\ \(0\)\
\-\ were\\:\\ 0\\.005774661716339051\ \(0\)\
\-\ well\\:\\ 0\\.005753217121930509\ \(0\)\
\-\ left\\:\\ 0\\.005691102793291158\ \(0\)\
\-\ year\\:\\ 0\\.005691102793291158\ \(0\)\
\-\ exam\\:\\ 0\\.00558700577365934\ \(0\)\
\-\ 2\\:\\ 0\\.005476501477709958\ \(0\)\
\-\ multiple\\:\\ 0\\.005356565486545443\ \(0\)\
\-\ presents\\:\\ 0\\.005195369927106922\ \(0\)\
\-\ lesion\\:\\ 0\\.005180223886906115\ \(0\)\
\-\ treatment\\:\\ 0\\.005147669522621687\ \(0\)\
\-\ seen\\:\\ 0\\.005025677425796697\ \(0\)\
\-\ which\\:\\ 0\\.004747454128698062\ \(0\)\
\-\ for\\:\\ 0\\.004339929456206638\ \(0\)\
\-\ from\\:\\ 0\\.0037691539081970604\ \(0\)\
\-\ and\\:\\ 0\\.0037501876194212178\ \(0\)\
\-\ ct\\:\\ 0\\.0035574513493810797\ \(0\)\
\-\ history\\:\\ 0\\.003512543266985367\ \(0\)\
\-\ at\\:\\ 0\\.0034457236691417645\ \(0\)\
\-\ old\\:\\ 0\\.0026039720144709956\ \(0\)\
\-\ no\\:\\ 0\\.0025608456866184582\ \(0\)\
\-\ patient\\:\\ 0\\.002549380746774964\ \(0\)\
\-\ to\\:\\ 0\\.0025420720740653943\ \(0\)\
\-\ in\\:\\ 0\\.0025083168460729457\ \(0\)\
\-\ of\\:\\ 0\\.0024271625166247587\ \(0\)\
\-\ on\\:\\ 0\\.002154437536801869\ \(0\)\
\-\ the\\:\\ 0\\.002057281022375384\ \(0\)\
\-\ \\.\\:\\ 0\\.0020074142435999383\ \(0\)\
\-\ a\\:\\ 0\\.0011803565530315514\ \(0\)\
\-\ with\\:\\ 0\\.0010446801436597298\ \(0\)\
